Amedeo Smart

Free Medical Literature Service

 

Amedeo

Parkinson's Disease
  Free Subscription

Articles published in
PLoS One
    January 2026
  1. DENG X, Yan X, Song Z, Zheng W, et al
    Genetic analysis of LRRK2 variants in Han Chinese patients with Parkinson's disease.
    PLoS One. 2026;21:e0340448.
    >> Share

  2. ABU-BAIH DH, Elmaidomy AH, Abou-Zied HA, Hussien NA, et al
    Emphasizing the role of oxidative stress and Sirt-1/Nrf2 and TLR-4/NF-kappaB in Tamarix aphylla mediated neuroprotective potential in rotenone-induced Parkinson's disease: In silico and in vivo study.
    PLoS One. 2026;21:e0339010.
    >> Share

  3. LIU W, Xu L, Wang X, Wang J, et al
    Integrative multi-omics and network-based machine learning for early diagnosis of Parkinson's disease.
    PLoS One. 2026;21:e0329980.
    >> Share

  4. WALL C, Sacre A, McMeekin P, Walker R, et al
    Parkinson's disease gait rehabilitation at scale: Insights on personalised smartphone-based music cueing.
    PLoS One. 2026;21:e0340106.
    >> Share

  5. CHENNA S, Joselin A, Theurey P, Bano D, et al
    Integrating simulated and experimental data to identify mitochondrial bioenergetic defects in Parkinson's Disease models.
    PLoS One. 2026;21:e0339326.
    >> Share


  6. Correction: Personalized versus fixed tactile cueing in Parkinson's disease: Protocol for a randomized controlled trial on gait automaticity.
    PLoS One. 2026;21:e0341730.
    >> Share

  7. ROSAL AE, Torres-Carmona E, Martin SL, Boileau I, et al
    The effect of Apolipoprotein E4 on cognitive function in Parkinson's disease: A structural MRI study in the PPMI cohort.
    PLoS One. 2026;21:e0341240.
    >> Share

  8. ASGHAR A, Chohan TA, Qayyum A, Rana SM, et al
    Unveiling the biochemical potential of Acacia jacquemontii as a therapeutic agent in parkinson's disease: A multi-model in Vitro, In Vivo, and In Silico Study.
    PLoS One. 2026;21:e0334312.
    >> Share

  9. DUPPEN CP, Surkin J, Mahendar S, Saunders J, et al
    The influence of visual input and attention on gait initiation in people with Parkinson disease.
    PLoS One. 2026;21:e0342661.
    >> Share

  10. LATELLA D, Lombardo Facciale A, Bonanno M, Bonanno L, et al
    Enhancing gait training with anti-gravity treadmill 'Alter-G' in patients with Parkinson's disease.
    PLoS One. 2026;21:e0341021.
    >> Share

  11. MUHAMMAD J, Ghergherehchi M, Ali S, Seung Song H, et al
    Trustworthy AI for medical decisions: Adversarially robust and fair machine learning prediction for Parkinson's disease.
    PLoS One. 2026;21:e0342062.
    >> Share

  12. BAGGEN RJ, Van Bladel A, Prins MR, Stappers J, et al
    Visual perturbation training to reduce visual dependency in Parkinson's disease: A randomized controlled trial.
    PLoS One. 2026;21:e0343223.
    >> Share

  13. VASCONCELLOS LS, Taveira RS, de Melo LP, de Macedo Borges LRD, et al
    Effects of telerehabilitation-based physical therapy for individuals with Parkinson's disease: A systematic review protocol.
    PLoS One. 2026;21:e0342771.
    >> Share

  14. ZUO M, Li J, Chang M, Zhang Q, et al
    Robust 3D Pose estimation and Parkinson's Disease classification via Dual-Stage Adaptive Temporal Perception and graph topology modeling network.
    PLoS One. 2026;21:e0344375.
    >> Share

  15. KANG K, Arakawa R, Sterner I, Seemiller J, et al
    Effect of rhythmic auditory stimulation (RAS)(R) with and without melody on Parkinson's disease (PD) patients with deep brain stimulation (DBS): A study protocol.
    PLoS One. 2026;21:e0344290.
    >> Share

  16. KUNUGITANI K, Sawamura M, Taguchi T, Hirato T, et al
    Evaluation of a commercial AI-assisted cell counting software for dopaminergic neurons across species.
    PLoS One. 2026;21:e0344621.
    >> Share

  17. MORCILLO-MARTINEZ L, Sanz-Marmol M, Romanos-Navarrete AI, Calvo S, et al
    Effects of a level-based immersive virtual reality physical therapy program on static and dynamic balance in Parkinson's disease: Protocol for a randomized controlled trial.
    PLoS One. 2026;21:e0344457.
    >> Share

  18. ZANATTA F, Steca P, Fundaro C, Giardini A, et al
    Longitudinal evidence of technology-enhanced, individualized neuromotor rehabilitation on autonomy, cognition, quality of life, and psychological well-being: Pilot multi-sample study.
    PLoS One. 2026;21:e0344472.
    >> Share

    January 2025
  19. CONNIE T, Aderinola TB, Ong JY, Ong TS, et al
    Parkinson's disease screening using a fusion of gait point cloud and silhouette features.
    PLoS One. 2025;20:e0315453.
    >> Share

  20. SONG H, Ge S, Li J, Jiao C, et al
    Effects of aerobic and resistance training on walking and balance abilities in older adults with Parkinson's disease: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0314539.
    >> Share

  21. GRAHAM L, Vitorio R, Walker R, Godfrey A, et al
    Digital measurement of ocular microtremor in Parkinson's disease: Protocol for a pilot study to assess reliability and clinical validation.
    PLoS One. 2025;20:e0313452.
    >> Share

  22. YU B, Zhang H, Zhang M
    Deep learning-based differential gut flora for prediction of Parkinson's.
    PLoS One. 2025;20:e0310005.
    >> Share

  23. ZHANG L, Jiang Y, Fan W, Xue H, et al
    Unveiling the efficacy of repetitive transcranial magnetic stimulation in Parkinson's disease: A comprehensive review of systematic analyses.
    PLoS One. 2025;20:e0313420.
    >> Share

  24. RUKAVINA K, Staunton J, Zinzalias P, Krbot Skoric M, et al
    Wearable devices may aid the recognition of fluctuation-related pain in Parkinson's disease-An exploratory, cross-sectional analysis of two prospective observational studies.
    PLoS One. 2025;20:e0316563.
    >> Share

  25. LEE J, Kang SH, Koh SB
    Postural instability and gait disturbance are associated with abnormal stereopsis in Parkinson's disease.
    PLoS One. 2025;20:e0317935.
    >> Share

  26. LU H, Qi G, Wu D, Lin C, et al
    A novel feature extraction method based on dynamic handwriting for Parkinson's disease detection.
    PLoS One. 2025;20:e0318021.
    >> Share

  27. KIM J, Kim R, Byun K, Kang N, et al
    Assessment of temporospatial and kinematic gait parameters using human pose estimation in patients with Parkinson's disease: A comparison between near-frontal and lateral views.
    PLoS One. 2025;20:e0317933.
    >> Share

  28. DE ALMEIDA SB, Tavares Sobreira ES, de Lucena Alves CP, Lima DP, et al
    Effect of power training on physical functional performance of patients with Parkinson's disease: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2025;20:e0314058.
    >> Share

  29. GERMANI E, Bhagwat N, Dugre M, Gau R, et al
    Predicting Parkinson's disease trajectory using clinical and functional MRI features: A reproduction and replication study.
    PLoS One. 2025;20:e0317566.
    >> Share

  30. BECK EN, Wang MTY, Intzandt BN, Almeida QJ, et al
    Correction: Sensory focused exercise improves anxiety in Parkinson's disease: A randomized controlled trial.
    PLoS One. 2025;20:e0319768.
    >> Share


  31. Retraction: TOM40 Mediates Mitochondrial Dysfunction Induced by alpha-Synuclein Accumulation in Parkinson's Disease.
    PLoS One. 2025;20:e0319935.
    >> Share

  32. ABOELZAHAB YH, Bojmehrani A, Ahmed YE, Boon H, et al
    Psychological stress associated with prognostic uncertainties in recently diagnosed Parkinson's disease patients: A qualitative study.
    PLoS One. 2025;20:e0319576.
    >> Share

  33. GOMEZ LF, Morales A, Fierrez J, Orozco-Arroyave JR, et al
    Correction: Exploring facial expressions and action unit domains for Parkinson detection.
    PLoS One. 2025;20:e0320872.
    >> Share


  34. Retraction: Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases.
    PLoS One. 2025;20:e0321152.
    >> Share

  35. HUO H, Jiao S, Li D, Ma L, et al
    Efficient quantification of Parkinson's disease severity using augmented time-series data.
    PLoS One. 2025;20:e0319826.
    >> Share

  36. SANTOS-GARCIA D, Gonzalez-Ortega G, Sanchez-Alonso P, Planas-Ballve A, et al
    Device-aided therapies (DATs) in Parkinson's disease (PD). The DATs-PD GETM Spanish Registry Protocol Study.
    PLoS One. 2025;20:e0316052.
    >> Share

  37. ESTIVALET KM, Pettenuzzo TSA, Mazzilli NL, Ferreira LF, et al
    The use of brain-machine interface, motor imagery, and action observation in the rehabilitation of individuals with Parkinson's disease: A protocol study for a randomized clinical trial.
    PLoS One. 2025;20:e0315148.
    >> Share

  38. HODGSON P, Jordan A, Sinani C, Charura D, et al
    The relationship between physical function and psychological symptoms in Parkinson's: Perceptions of People with Parkinson's and Carers.
    PLoS One. 2025;20:e0310578.
    >> Share

  39. KIM J, Park S, Lee JH, Lee JY, et al
    Zinc finger protein 184 prevents alpha-synuclein preformed fibril-mediated neurodegeneration through the interleukin enhancer binding factor 3-microRNA-7 pathway.
    PLoS One. 2025;20:e0323279.
    >> Share

  40. OKAI T, Sato S, Deshpande M, Matsumoto SI, et al
    AAV delivery of GBA1 suppresses alpha-synuclein accumulation in Parkinson's disease models and restores functions in Gaucher's disease models.
    PLoS One. 2025;20:e0321145.
    >> Share

  41. ABAQUITA TAL, Damulewicz M, Pyza E
    The neuroprotective role of CncC in a Drosophila model of Parkinson's disease.
    PLoS One. 2025;20:e0322640.
    >> Share

  42. GORENFLO MP, Gao Z, Davis PB, Kaelber D, et al
    Amphetamine use and Parkinson's disease: integration of artificial intelligence prediction, clinical corroboration, and mechanism of action analyses.
    PLoS One. 2025;20:e0323761.
    >> Share

  43. LI Y, Jia W, Chen C, Chen C, et al
    Identification of biomarkers associated with inflammatory response in Parkinson's disease by bioinformatics and machine learning.
    PLoS One. 2025;20:e0320257.
    >> Share

  44. ORAYJ K
    Trends in Parkinson's disease medication prescribing patterns in the UK: An interrupted time series analysis (2019-2024).
    PLoS One. 2025;20:e0324999.
    >> Share

  45. MENDORF S, Heimrich KG, Muhlhammer HM, Schonenberg A, et al
    The influence of the Big Five inventory on quality of life in people with Parkinson's disease aged 50 and above: A Longitudinal Analysis from the Survey of Health, Aging and Retirement in Europe (SHARE).
    PLoS One. 2025;20:e0322089.
    >> Share

  46. LANDER JJ, Moran MF, Alexanian HR
    Correlations of gait kinematics and cognitive skills in Parkinson disease.
    PLoS One. 2025;20:e0317389.
    >> Share

  47. IBRAHIM MK, Mohammed SI, Al-Gawwam GAAS
    Neurologists' perspectives on management challenges and mitigation strategies for Parkinson's disease patients: A qualitative study in Iraq.
    PLoS One. 2025;20:e0326851.
    >> Share

  48. YADAV R, Dey S, Kumar R, Mohanan AP, et al
    Progression and natural history of Atypical Parkinsonism (ATPARK): Protocol for a longitudinal follow-up study from an underrepresented population.
    PLoS One. 2025;20:e0325624.
    >> Share

  49. BSOUL R, Simonsen AH, Frederiksen KS, Svenstrup K, et al
    Seeding amplification assay with Universal Control Fluid: Standardized detection of alpha-synucleinopathies.
    PLoS One. 2025;20:e0326568.
    >> Share

  50. LIU T, Li J, Zhang J, Wei J, et al
    Cuproptosis-related genes associated with mitochondrial dysfunction in Parkinson's disease.
    PLoS One. 2025;20:e0327550.
    >> Share

  51. ZHU Z, Wu E, Leng P, Sun J, et al
    Finger drawing on smartphone screens enables early Parkinson's disease detection through hybrid 1D-CNN and BiGRU deep learning architecture.
    PLoS One. 2025;20:e0327733.
    >> Share

  52. CARAPELLOTTI AM, Rodger M, Doumas M
    Evaluating the short-term effects of dance on motor and non-motor outcomes in people living with Parkinson's: A crossover study.
    PLoS One. 2025;20:e0328293.
    >> Share

  53. KIM A, Schweighofer N, Petzinger GM, Finley JM, et al
    Uncovering locomotor learning dynamics in people with Parkinson's disease.
    PLoS One. 2025;20:e0326692.
    >> Share

  54. PAMLENYI K, Ferreira B, Regdon G Jr, Kristo K, et al
    Development and characterization of pramipexole dihydrochloride buccal films for Parkinson's disease treatment.
    PLoS One. 2025;20:e0329142.
    >> Share

  55. JOINEAU K, Harroch E, Boussac M, Fabbri M, et al
    Effect of foot reflexology on chronic pain in Parkinson's disease: A randomized controlled trial.
    PLoS One. 2025;20:e0327865.
    >> Share

  56. WANG H, Feng L, He L, Liu N, et al
    Bioinformatics analysis to explore biomarkers and mechanisms of action associated with endoplasmic reticulum stress and ferroptosis in Parkinson's disease.
    PLoS One. 2025;20:e0328682.
    >> Share

  57. POLINSKI NK, Puolivali J, Rauhala L, Stenius TK, et al
    Expression of human A53T alpha-synuclein without endogenous rat alpha-synuclein fails to elicit Parkinson's disease-related phenotypes in a novel humanized rat model.
    PLoS One. 2025;20:e0329823.
    >> Share

  58. KASEMSAP N, Tikkapanyo P, Wanjantuk P, Vorasoot N, et al
    Screening for Parkinson's disease using "computer vision".
    PLoS One. 2025;20:e0330373.
    >> Share

  59. UMEMURA A, Sato K, Iwamuro H, Uchiyama S, et al
    Effects of transcranial direct current stimulation using a commercially available device on gait in Parkinson's disease with freezing of gait.
    PLoS One. 2025;20:e0330286.
    >> Share

  60. LARSSON V, Hall S, Blennow K, Hansson O, et al
    Olfactory dysfunction and amyloid-positivity in Parkinson's disease-longitudinal analysis of cognitive decline and cerebrospinal fluid markers.
    PLoS One. 2025;20:e0325560.
    >> Share

  61. PAPIC E, Racki V, Hero M, Zimani AN, et al
    Microbial diversity in drug-naive Parkinson's disease patients.
    PLoS One. 2025;20:e0328761.
    >> Share

  62. NOROUZI-GHAZBI S, Mirbaha S, Li Z, Andrysek J, et al
    Gamification-based tele-rehabilitation for physical therapy in patients with Parkinson's disease: A scoping review.
    PLoS One. 2025;20:e0326705.
    >> Share


  63. Expression of Concern: The IkappaB Kinase Family Phosphorylates the Parkinson's Disease Kinase LRRK2 at Ser935 and Ser910 during Toll-Like Receptor Signaling.
    PLoS One. 2025;20:e0330958.
    >> Share

  64. RODRIGUEZ-MARTIN D, Catala A, Cabestany J
    Improving Parkinson's disease management through wearable technology: A cost-benefit perspective.
    PLoS One. 2025;20:e0334413.
    >> Share

  65. NAYAN NM, Rana AM, Islam MM, Uddin J, et al
    An interpretable and balanced machine learning framework for Parkinson's disease prediction using feature engineering and explainable AI.
    PLoS One. 2025;20:e0333418.
    >> Share

  66. BURGOS PI, Liu W, Silva-Batista C, Baker-Alcala F, et al
    Personalized versus fixed tactile cueing in Parkinson's disease: Protocol for a randomized controlled trial on gait automaticity.
    PLoS One. 2025;20:e0336859.
    >> Share

  67. WEN J, Chen A, Liu J, Xiong H, et al
    Cross-modal fusion of brain imaging and clinical data for Parkinson's disease progression prediction.
    PLoS One. 2025;20:e0333822.
    >> Share

  68. DENNIS AP, Martin SL, Chen R, Gerretsen P, et al
    Using machine learning for detection of Parkinson's disease and mild cognitive impairment.
    PLoS One. 2025;20:e0335541.
    >> Share

  69. LI Z, Hu P
    Exercise: The key to enhancing sleep quality and physical function in Parkinson's disease? A systematic review and meta-analysis.
    PLoS One. 2025;20:e0336381.
    >> Share

  70. OHLHAUSER L, Kwan H, Casey H, MacDonald S, et al
    Sex similarities and differences in cognition: A longitudinal study of healthy control participants from the Parkinson Progression Markers Initiative.
    PLoS One. 2025;20:e0334358.
    >> Share

  71. GUO L, Li Q, Li J, Yang F, et al
    ceRNA regulatory network and immune-neurodegenerative mechanisms of peripheral CD4+ T cells in parkinson's disease.
    PLoS One. 2025;20:e0337808.
    >> Share

  72. BJORKDAHL A, Fristedt S, Filipowicz K, Bergman P, et al
    A small-scale study on dancing for people living with Parkinson's disease.
    PLoS One. 2025;20:e0335433.
    >> Share

  73. TAN QY, Ibrahim K, Roberts HC, Amar K, et al
    A mixed-methods study to explore the modifiable aspects of treatment burden in Parkinson's disease and develop recommendations for improvement.
    PLoS One. 2025;20:e0338620.
    >> Share

  74. WUNNENBERG E, Baumann N
    Group singing through the lens of polyvagal theory: A pilot study in patients with Parkinson's disease.
    PLoS One. 2025;20:e0337210.
    >> Share

    January 2024
  75. KIM M, Kim D, Kang H, Park S, et al
    A machine learning model for prediction of sarcopenia in patients with Parkinson's Disease.
    PLoS One. 2024;19:e0296282.
    >> Share

  76. BRUNI F, Mancuso V, Stramba-Badiale C, Stramba-Badiale M, et al
    Beyond traditional training: Integrating data from semi-immersive VR dual-task intervention in Parkinsonian Syndromes. A study protocol.
    PLoS One. 2024;19:e0294199.
    >> Share

  77. SOKOLOWSKI A, Bhagwat N, Chatelain Y, Dugre M, et al
    Longitudinal brain structure changes in Parkinson's disease: A replication study.
    PLoS One. 2024;19:e0295069.
    >> Share

  78. ESSAWY ESSAWY A, Abou-ElNaga OA, Mehanna RA, Badae NM, et al
    Comparing the effect of intravenous versus intracranial grafting of mesenchymal stem cells against parkinsonism in a rat model: Behavioral, biochemical, pathological and immunohistochemical studies.
    PLoS One. 2024;19:e0296297.
    >> Share

  79. WAWRZICZNY E, Flinois B, Constant E, Brugalle E, et al
    Dealing with the diagnosis of Parkinson's disease and its implications for couple functioning in the early stage: An interpretative phenomenological analysis.
    PLoS One. 2024;19:e0294240.
    >> Share

  80. MEIJER LL, Ruis C, Schielen ZA, Dijkerman HC, et al
    CT-optimal touch and chronic pain experience in Parkinson's Disease; An intervention study.
    PLoS One. 2024;19:e0298345.
    >> Share

  81. TIAN J, Zuo C, Shi J, Ma D, et al
    Peripheral immune cell traits and Parkinson's disease: A Mendelian randomization study.
    PLoS One. 2024;19:e0299026.
    >> Share

  82. MALAGUTI MC, Gios L, Giometto B, Longo C, et al
    Artificial intelligence of imaging and clinical neurological data for predictive, preventive and personalized (P3) medicine for Parkinson Disease: The NeuroArtP3 protocol for a multi-center research study.
    PLoS One. 2024;19:e0300127.
    >> Share

  83. VARGA I, Bakstein E, Gilmore G, May J, et al
    Statistical segmentation model for accurate electrode positioning in Parkinson's deep brain stimulation based on clinical low-resolution image data and electrophysiology.
    PLoS One. 2024;19:e0298320.
    >> Share

  84. SEUTHE J, Heinzel A, Hulzinga F, Ginis P, et al
    Towards a better understanding of anticipatory postural adjustments in people with Parkinson's disease.
    PLoS One. 2024;19:e0300465.
    >> Share

  85. SCHRAG A, Kostev K
    Association of antihypertensives and Parkinson's disease in a primary care population matched for underlying diagnosis.
    PLoS One. 2024;19:e0299985.
    >> Share

  86. CAI X, Jin Z, Zhang S, Liu J, et al
    Sjogren's syndrome and Parkinson's Disease: A bidirectional two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0298778.
    >> Share

  87. MCMAHON L, McGrath D, Blake C, Lennon O, et al
    Responsiveness of respiratory function in Parkinson's Disease to an integrative exercise programme: A prospective cohort study.
    PLoS One. 2024;19:e0301433.
    >> Share

  88. SAADULLAH M, Tariq H, Chauhdary Z, Saleem U, et al
    Biochemical properties and biological potential of Syzygium heyneanum with antiparkinson's activity in paraquat induced rodent model.
    PLoS One. 2024;19:e0298986.
    >> Share

  89. KHAN A, Ezeugwa J, Ezeugwu VE
    A systematic review of the associations between sedentary behavior, physical inactivity, and non-motor symptoms of Parkinson's disease.
    PLoS One. 2024;19:e0293382.
    >> Share

  90. SONG J, Li J, Pei X, Chen J, et al
    Identification of cuproptosis-realated key genes and pathways in Parkinson's disease via bioinformatics analysis.
    PLoS One. 2024;19:e0299898.
    >> Share

  91. ANJUM R, Raza C, Faheem M, Ullah A, et al
    Neuroprotective potential of Mentha piperita extract prevents motor dysfunctions in mouse model of Parkinson's disease through anti-oxidant capacities.
    PLoS One. 2024;19:e0302102.
    >> Share

  92. MORACA GAG, Orcioli-Silva D, Legutke BR, Gutierrez PP, et al
    Aerobic exercise on the treadmill combined with transcranial direct current stimulation on the gait of people with Parkinson's disease: A protocol for a randomized clinical trial.
    PLoS One. 2024;19:e0300243.
    >> Share

  93. VARGA I, Bakstein E, Gilmore G, May J, et al
    Correction: Statistical segmentation model for accurate electrode positioning in Parkinson's deep brain stimulation based on clinical low-resolution image data and electrophysiology.
    PLoS One. 2024;19:e0302985.
    >> Share

  94. TABARI F, Berger JI, Flouty O, Copeland B, et al
    Speech, voice, and language outcomes following deep brain stimulation: A systematic review.
    PLoS One. 2024;19:e0302739.
    >> Share

  95. ZHANG HW, Xie J, Peng HC, Lin YS, et al
    Use of antiviral drugs and incidence of Parkinson's disease in Taiwan.
    PLoS One. 2024;19:e0302383.
    >> Share

  96. PARK MS, Park S, Kang JY, Jung IC, et al
    The efficacy and safety of MARS-PD: Meridian activation remedy system for Parkinson's disease-A single-center, assessor and statistician-blinded, parallel-group randomized, controlled trial protocol.
    PLoS One. 2024;19:e0303156.
    >> Share

  97. ALTHAM C, Zhang H, Pereira E
    Machine learning for the detection and diagnosis of cognitive impairment in Parkinson's Disease: A systematic review.
    PLoS One. 2024;19:e0303644.
    >> Share

  98. MILDNER S, Hotz I, Kubler F, Rausch L, et al
    Effects of activity-oriented physiotherapy with and without eye movement training on dynamic balance, functional mobility, and eye movements in patients with Parkinson's disease: An assessor-blinded randomised controlled pilot trial.
    PLoS One. 2024;19:e0304788.
    >> Share

  99. HARRIS DM, O'Bryan SJ, Latella C
    Non-invasive brain stimulation as treatment for motor impairment in people with Parkinson's disease: Protocol for an umbrella review.
    PLoS One. 2024;19:e0304717.
    >> Share

  100. AGLEY L, Hartley P, Lafortune L
    Exploring the experiences, priorities and preferences of people living with Parkinson's on exercise and physical activity promotion in the UK.
    PLoS One. 2024;19:e0304223.
    >> Share

  101. CRIGHTON EJ, Ouedraogo AM, Sawada M, Mestre TA, et al
    Patterns and determinants of health care utilization among people with Parkinson's disease: A population-based analysis in Ontario, Canada.
    PLoS One. 2024;19:e0305062.
    >> Share

  102. YALCIN M, Peralta AR, Bentes C, Silva C, et al
    Molecular characterization of the circadian clock in patients with Parkinson's disease-CLOCK4PD Study protocol.
    PLoS One. 2024;19:e0305712.
    >> Share

  103. GORJI A, Fathi Jouzdani A
    Machine learning for predicting cognitive decline within five years in Parkinson's disease: Comparing cognitive assessment scales with DAT SPECT and clinical biomarkers.
    PLoS One. 2024;19:e0304355.
    >> Share

  104. BOSCH-BARCELO P, Climent-Sanz C, Martinez-Navarro O, Masbernat-Almenara M, et al
    A treadmill training program in a gamified virtual reality environment combined with transcranial direct current stimulation in Parkinson's Disease: Study protocol for a randomized controlled trial.
    PLoS One. 2024;19:e0307304.
    >> Share

  105. WANG K, Han C, Yang J, Xu W, et al
    Benfotiamine protects MPTP-induced Parkinson's disease mouse model via activating Nrf2 signaling pathway.
    PLoS One. 2024;19:e0307012.
    >> Share

  106. STEINBACH S, Molina M, Grinberg LT, Aring L, et al
    Don't die like me: Which proteins are responsible for the selective neuronal vulnerability within the substantia nigra?
    PLoS One. 2024;19:e0296730.
    >> Share

  107. FUNG KW, Baye F, Baik SH, McDonald CJ, et al
    Tamsulosin use in benign prostatic hyperplasia and risks of Parkinson's disease, Alzheimer's disease and mortality: An observational cohort study of elderly Medicare enrollees.
    PLoS One. 2024;19:e0309222.
    >> Share

  108. USAMI N, Maegawa H, Hayashi M, Kudo C, et al
    Changes in the analgesic mechanism of oxytocin can contribute to hyperalgesia in Parkinson's disease model rats.
    PLoS One. 2024;19:e0300081.
    >> Share

  109. THIES T, Barbe MT, Mucke D
    Prosody matters: Preserved prominence marking strategies in people with Parkinson's disease independent of motor status.
    PLoS One. 2024;19:e0308655.
    >> Share

  110. PETERSEN I, Godec A, Ranjbarian F, Hofer A, et al
    A charged tail on anti-alpha-Synuclein antibodies does not enhance their affinity to alpha-Synuclein fibrils.
    PLoS One. 2024;19:e0308521.
    >> Share

  111. MORAES IAP, Collett J, Silva TDD, Franssen M, et al
    Sensorimotor functioning changes in response to global exercise versus handwriting upper limb exercise training in Parkinson's disease, results from a phase II randomised controlled trial.
    PLoS One. 2024;19:e0309217.
    >> Share

  112. RAMIREZ J, Saleh IG, Yanagawa ESK, Shimogawa M, et al
    Multivalency drives interactions of alpha-synuclein fibrils with tau.
    PLoS One. 2024;19:e0309416.
    >> Share

  113. XU N, Xing S, Li J, Pang B, et al
    Water extract of ginseng alleviates parkinsonism in MPTP-induced Parkinson's disease mice.
    PLoS One. 2024;19:e0296424.
    >> Share

  114. MINNELLA A, McCusker KP, Amagata A, Trias B, et al
    Targeting ferroptosis with the lipoxygenase inhibitor PTC-041 as a therapeutic strategy for the treatment of Parkinson's disease.
    PLoS One. 2024;19:e0309893.
    >> Share

  115. LIU K, An J, Zhang J, Zhao J, et al
    Network pharmacology combined with experimental validation show that apigenin as the active ingredient of Campsis grandiflora flower against Parkinson's disease by inhibiting the PI3K/AKT/NF-kappaB pathway.
    PLoS One. 2024;19:e0311824.
    >> Share

  116. HERATH HMMTB, Wijayawardhana KWSM, Wickramarachchi UI, Senanayake S, et al
    Impulse control disorders and other non-motor symptoms in Sri Lankan patients with Parkinson's disease.
    PLoS One. 2024;19:e0312342.
    >> Share

  117. SAIBENE FL, Agliardi C, Salvatore A, Arcuri P, et al
    Investigating the effects of a daily multidisciplinary intensive outpatient rehabilitation program on innovative biomarkers in people with Parkinson's disease: Study protocol for a phase III randomized controlled clinical trial.
    PLoS One. 2024;19:e0309405.
    >> Share

  118. NOMOTO M, Tsuboi Y, Kashihara K, Chiu SW, et al
    Prescription trends in Japanese advanced Parkinson's disease patients with non-motor symptoms: J-FIRST.
    PLoS One. 2024;19:e0309297.
    >> Share

  119. PARK S, Lee J, Kim JY, Park JH, et al
    Clinical significance of MRI-measured olfactory bulb height as an imaging biomarker of idiopathic Parkinson's disease.
    PLoS One. 2024;19:e0312728.
    >> Share

  120. MOHD AMIN NI, Mohd Nordin NA, Ismail A, Pillai SGK, et al
    A single-blind, randomised control trial on the effectiveness of a structured multi component training module for family caregiver of persons with Parkinson's disease: A study protocol.
    PLoS One. 2024;19:e0309648.
    >> Share

  121. WANG Z, Xia H, Ding Y, Lu R, et al
    No association between genetically predicted vitamin D levels and Parkinson's disease.
    PLoS One. 2024;19:e0313631.
    >> Share

  122. KHAN A, Ullah F, Alkreathy HM, Ahmed M, et al
    Phytochemical screening, antioxidant and anti-Parkinson activities of Berula erecta: A novel medicinal plant.
    PLoS One. 2024;19:e0305751.
    >> Share

  123. REGAN EW, Burnitz O, Hightower J, Dobner L, et al
    Rock Steady Boxing: A qualitative evaluation of a community exercise program for people with Parkinson's disease.
    PLoS One. 2024;19:e0309522.
    >> Share

  124. NAGY NS, Helal M, Alsawy ES, Ali MM, et al
    Paracentrotus lividus sea urchin gonadal extract mitigates neurotoxicity and inflammatory signaling in a rat model of Parkinson's disease.
    PLoS One. 2024;19:e0315858.
    >> Share

  125. CARMICHAEL-LOWE A, Fleming B, Reddy K, Wiseman J, et al
    Enhanced detection of distinct honeycomb-structured neuronal SMARCC2 cytobodies in Parkinson's Disease via Cyclic Heat-Induced Epitope Retrieval (CHIER).
    PLoS One. 2024;19:e0315183.
    >> Share


  126. Retraction: GDNF-Transfected Macrophages Produce Potent Neuroprotective Effects in Parkinson's Disease Mouse Model.
    PLoS One. 2024;19:e0314546.
    >> Share

  127. HODGSON P, Jordan A, Sinani C, Charura D, et al
    Psycho-physical interactions in Parkinson's Disease: Protocol for a prospective observational cohort study.
    PLoS One. 2024;19:e0315345.
    >> Share

  128. SHIM SR, Kim JY, Kwon KY, Shin J, et al
    Effects of rivastigmine on gait in patients with neurodegenerative disorders: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0310900.
    >> Share

  129. SAADULLAH M, Sehar A, Chauhdary Z, Siddique R, et al
    Anti-neuroinflammatory and neuroprotective potential of Cissus tuberosa ethanol extract in Parkinson's disease model through the modulation of neuroinflammatory markers.
    PLoS One. 2024;19:e0311140.
    >> Share

  130. LI T, Guo J
    Identifying the NEAT1/miR-26b-5p/S100A2 axis as a regulator in Parkinson's disease based on the ferroptosis-related genes.
    PLoS One. 2024;19:e0316179.
    >> Share

  131. PINTO C, Simon Myra R, Severo do Pinho A, Pereira F, et al
    Quality assessment and umbrella review of systematic reviews about dance for people with Parkinson's disease.
    PLoS One. 2024;19:e0311003.
    >> Share

    January 2023
  132. CHUNG JW, Knight CA, Bower AE, Martello JP, et al
    Rate control deficits during pinch grip and ankle dorsiflexion in early-stage Parkinson's disease.
    PLoS One. 2023;18:e0282203.
    >> Share

  133. CARVAJAL-OLIVEROS A, Dominguez-Baleon C, Sanchez-Diaz I, Zambrano-Tipan D, et al
    Parkinsonian phenotypes induced by Synphilin-1 expression are differentially contributed by serotonergic and dopaminergic circuits and suppressed by nicotine treatment.
    PLoS One. 2023;18:e0282348.
    >> Share

  134. ALI DE, Bassam SM, Elatrebi S, Habiba ES, et al
    HR LC-MS/MS metabolomic profiling of Yucca aloifolia fruit and the potential neuroprotective effect on rotenone-induced Parkinson's disease in rats.
    PLoS One. 2023;18:e0282246.
    >> Share

  135. TAN QY, Roberts HC, Fraser SDS, Amar K, et al
    What are the modifiable factors of treatment burden and capacity among people with Parkinson's disease and their caregivers: A qualitative study.
    PLoS One. 2023;18:e0283713.
    >> Share

  136. VAN DER LIJN I, de Haan GA, van der Feen FE, Huizinga F, et al
    Prevalence and nature of self-reported visual complaints in people with Parkinson's disease-Outcome of the Screening Visual Complaints questionnaire.
    PLoS One. 2023;18:e0283122.
    >> Share

  137. HWANG KS, Langley J, Tripathi R, Hu XP, et al
    In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson's disease using neuromelanin-sensitive MRI: Replication in two cohorts.
    PLoS One. 2023;18:e0282684.
    >> Share

  138. CAMPI M, Peters GW, Toczydlowska D
    Ataxic speech disorders and Parkinson's disease diagnostics via stochastic embedding of empirical mode decomposition.
    PLoS One. 2023;18:e0284667.
    >> Share

  139. ANWER DM, Gubinelli F, Kurt YA, Sarauskyte L, et al
    A comparison of machine learning approaches for the quantification of microglial cells in the brain of mice, rats and non-human primates.
    PLoS One. 2023;18:e0284480.
    >> Share

  140. ALLWRIGHT M, Mundell H, Sutherland G, Austin P, et al
    Machine learning analysis of the UK Biobank reveals IGF-1 and inflammatory biomarkers predict Parkinson's disease risk.
    PLoS One. 2023;18:e0285416.
    >> Share

  141. MACLAGAN LC, Marras C, Sewell IJ, Wu CF, et al
    Trends in health service use among persons with Parkinson's disease by rurality: A population-based repeated cross-sectional study.
    PLoS One. 2023;18:e0285585.
    >> Share

  142. HIRANO M, Samukawa M, Isono C, Nagai Y, et al
    The effects of safinamide on dysphagia in Parkinson's disease.
    PLoS One. 2023;18:e0286066.
    >> Share

  143. DAS J, Barry G, Walker R, Vitorio R, et al
    The integration of technology into a home-based visuo-cognitive training intervention for people with Parkinson's: Is the future digital?
    PLoS One. 2023;18:e0285100.
    >> Share

  144. ESCHWEILER M, McCrum C, Giannouli E
    A registered report of a crossover study on the effects of face masks on walking adaptability in people with Parkinson's disease and multiple sclerosis.
    PLoS One. 2023;18:e0286402.
    >> Share

  145. CHAND DA, Scadeng M, Dieriks BV
    Absolute quantification of neuromelanin in formalin-fixed human brains using absorbance spectrophotometry.
    PLoS One. 2023;18:e0288327.
    >> Share

  146. MARTINDALE JM, Sarva H, Martino D, Gilbert DL, et al
    Study protocol: A cross-sectional survey of clinicians to identify barriers to clinical practice guideline implementation in the assessment and treatment of persistent tic disorders.
    PLoS One. 2023;18:e0288408.
    >> Share

  147. PARAJULI M, Amara AW, Shaban M
    Deep-learning detection of mild cognitive impairment from sleep electroencephalography for patients with Parkinson's disease.
    PLoS One. 2023;18:e0286506.
    >> Share

  148. SORRELL L, Leta V, Barnett A, Stevens K, et al
    Clinical features and outcomes of hospitalised patients with COVID-19 and Parkinsonian disorders: A multicentre UK-based study.
    PLoS One. 2023;18:e0285349.
    >> Share

  149. ZAMORA-URSULO MA, Perez-Becerra J, Tellez LA, Saderi N, et al
    Reversal of pathological motor behavior in a model of Parkinson's disease by striatal dopamine uncaging.
    PLoS One. 2023;18:e0290317.
    >> Share

  150. BRITO SAF, Scianni AA, Silveira BMF, Oliveira ERM, et al
    Effects of high-intensity respiratory muscle training on respiratory muscle strength in individuals with Parkinson's disease: Protocol of a randomized clinical trial.
    PLoS One. 2023;18:e0291051.
    >> Share

  151. CROOKS S, Carter G, Wilson CB, Wynne L, et al
    Exploring public perceptions and awareness of Parkinson's disease: A scoping review.
    PLoS One. 2023;18:e0291357.
    >> Share

  152. CHIU YS, Wu KJ, Yu SJ, Wu KL, et al
    Peptide immunization against the C-terminal of alpha-synuclein reduces locomotor activity in mice overexpressing alpha-synuclein.
    PLoS One. 2023;18:e0291927.
    >> Share

  153. BATTISTA L, Casali M, Brusa L, Radicati FG, et al
    Clinical assessment of a new wearable tool for continuous and objective recording of motor fluctuations and ON/OFF states in patients with Parkinson's disease.
    PLoS One. 2023;18:e0287139.
    >> Share

  154. VOLLSTEDT EJ, Madoev H, Aasly A, Ahmad-Annuar A, et al
    Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson's Disease Project.
    PLoS One. 2023;18:e0292180.
    >> Share

  155. OKEMUO AJ, Gallagher D, Dairo YM
    Effects of rebound exercises on balance and mobility of people with neurological disorders: A systematic review.
    PLoS One. 2023;18:e0292312.
    >> Share

  156. GUTOWSKI T, Antkiewicz R, Szlufik S
    Machine learning with optimization to create medicine intake schedules for Parkinson's disease patients.
    PLoS One. 2023;18:e0293123.
    >> Share

  157. PADILHA C, Souza R, Grossl FS, Gauer APM, et al
    Physical exercise and its effects on people with Parkinson's disease: Umbrella review.
    PLoS One. 2023;18:e0293826.
    >> Share

  158. THANPRASERTSUK S, Phowthongkum P, Hopetrungraung T, Poorirerngpoom C, et al
    Levodopa-induced dyskinesia in early-onset Parkinson's disease (EOPD) associates with glucocerebrosidase mutation: A next-generation sequencing study in EOPD patients in Thailand.
    PLoS One. 2023;18:e0293516.
    >> Share

  159. LEE SH, Chung KC
    USP7 attenuates endoplasmic reticulum stress-induced apoptotic cell death through deubiquitination and stabilization of FBXO7.
    PLoS One. 2023;18:e0290371.
    >> Share

  160. MCCANN E, Lee S, Coleman F, O'Sullivan JD, et al
    Pareidolias are a function of visuoperceptual impairment.
    PLoS One. 2023;18:e0293942.
    >> Share

  161. O'MALLEY N, Coote S, Staunton FM, O'Connor E, et al
    A core outcome set for evaluating the effectiveness of mixed-diagnosis falls prevention interventions for people with Multiple Sclerosis, Parkinson's Disease and stroke.
    PLoS One. 2023;18:e0294193.
    >> Share

  162. SENA IG, Costa AVD, Santos IKD, Araujo DP, et al
    Feasibility and effect of high-intensity training on the progression of motor symptoms in adult individuals with Parkinson's disease: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0293357.
    >> Share

  163. MAGANA JC, Deus CM, Baldellou L, Avellanet M, et al
    Investigating the impact of physical activity on mitochondrial function in Parkinson's disease (PARKEX): Study protocol for A randomized controlled clinical trial.
    PLoS One. 2023;18:e0293774.
    >> Share

  164. MORADI VASTEGANI S, Khoshnam SE, Ghafouri S, Bakhtiari N, et al
    Anethole attenuates motor dysfunctions, striatal neuronal activity deficiency and blood brain barrier permeability by decreasing striatal alpha-synuclein and oxidative stress in rotenone-induced Parkinson's disease of male rats.
    PLoS One. 2023;18:e0294612.
    >> Share

  165. XIN G, Niu J, Tian Q, Fu Y, et al
    Identification of potential immune-related hub genes in Parkinson's disease based on machine learning and development and validation of a diagnostic classification model.
    PLoS One. 2023;18:e0294984.
    >> Share

  166. HONG JT, Jung HK, Lee KJ, Gong EJ, et al
    Potential risk of proton pump inhibitors for Parkinson's disease: A nationwide nested case-control study.
    PLoS One. 2023;18:e0295981.
    >> Share

  167. CHEN L, Xin G, He Y, Tian Q, et al
    Study of molecular patterns associated with ferroptosis in Parkinson's disease and its immune signature.
    PLoS One. 2023;18:e0295699.
    >> Share

  168. BORGHESI F, Mancuso V, Bruni F, Cremascoli R, et al
    Mental flexibility assessment: A research protocol for patients with Parkinson's Disease and Anorexia Nervosa.
    PLoS One. 2023;18:e0293921.
    >> Share

  169. MERCER HM, Nair AM, Ridgel A, Piontkivska H, et al
    Alterations in RNA editing in skeletal muscle following exercise training in individuals with Parkinson's disease.
    PLoS One. 2023;18:e0287078.
    >> Share

  170. HATTORI N, Kabata D, Asada S, Kanda T, et al
    Real-world evidence on levodopa dose escalation in patients with Parkinson's disease treated with istradefylline.
    PLoS One. 2023;18:e0269969.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016